Liang-Chuan Wang

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors

Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi et al. · Clinical Cancer Research · 2014 · 410 citations · Full text

Life Sciences, Immunology, Oncology +16

Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery

Jarrod D. Predina, Evgeniy Eruslanov, Brendan F. Judy et al. · Proceedings of the National Academy of Sciences · 2012 · 193 citations · Full text

Medicine, Immunology, Oncology +17

Mesothelin, a novel immunotherapy target for triple negative breast cancer

Julia Tchou, Liang-Chuan Wang, Ben Selven et al. · Breast Cancer Research and Treatment · 2012 · 179 citations

Medicine, Immunology, Oncology +11

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade

Cecile Geuijen, Paul J. Tacken, Liang-Chuan Wang et al. · Nature Communications · 2021 · 114 citations · Full text

Life Sciences, Immunology, Oncology +17

Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Enxiu Wang, Liang-Chuan Wang, Ching‐Yi Tsai et al. · Cancer Immunology Research · 2015 · 113 citations · Full text

Life Sciences, Immunology, Oncology +17